From October 1, 2022 to December 31, 2022, the company has repurchased 540,000 shares, representing 0.1% for CNY 2.7 million. With this, the company has completed the repurchase of 7,198,500 shares, representing 1.28% for CNY 37.65 million under the buyback announced on July 15, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.07 CNY | -2.31% | -3.80% | -17.29% |
1st Jan change | Capi. | |
---|---|---|
-17.29% | 391M | |
+37.78% | 723B | |
+31.21% | 598B | |
-3.51% | 364B | |
+19.94% | 331B | |
+5.14% | 288B | |
+16.42% | 244B | |
-4.66% | 208B | |
+10.06% | 210B | |
+9.32% | 169B |
- Stock Market
- Equities
- 600222 Stock
- News Henan Taloph Pharmaceutical Stock Co.,Ltd
- Tranche Update on Henan Taloph Pharmaceutical Stock Co.,Ltd's Equity Buyback Plan announced on July 15, 2022.